Clinical trial
Pilot Study of Haloperidol to Treat Critical Illness Delirium
NCT00429676 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00429676 |
|---|---|
| Title | Pilot Study of Haloperidol to Treat Critical Illness Delirium |
| Official title | A Randomized Prospective Pilot Study Of Haloperidol In Addition To Standard Sedation In Mechanically Ventilated Patients With Delirium |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | Denver Health Medical Center |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Delirium, Critical Illness |
| Intervention type | Drug |
| Interventions | Haloperidol |
| Enrollment | 20 |
| Start date | Dec 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Feb 1, 2007 |
| Last update posted | Nov 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: